BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18490052)

  • 41. Up-regulated expression of MIF by interfacial membrane fibroblasts and macrophages around aseptically loosened implants.
    Pan X; Mao X; Cheng T; Peng X; Zhang X; Liu Z; Wang Q; Chen Y
    J Surg Res; 2012 Aug; 176(2):484-9. PubMed ID: 22099602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
    Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
    Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles.
    Pioletti DP; Leoni L; Genini D; Takei H; Du P; Corbeil J
    J Biomed Mater Res; 2002 Sep; 61(3):408-20. PubMed ID: 12115466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Particle-induced osteolysis mediated by endoplasmic reticulum stress in prosthesis loosening.
    Wang R; Wang Z; Ma Y; Liu G; Shi H; Chen J; Dong L; Zhao J; Zhang J
    Biomaterials; 2013 Apr; 34(11):2611-23. PubMed ID: 23347837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of osteoblasts in peri-prosthetic osteolysis.
    O'Neill SC; Queally JM; Devitt BM; Doran PP; O'Byrne JM
    Bone Joint J; 2013 Aug; 95-B(8):1022-6. PubMed ID: 23908414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the outcome of cemented all-polyethylene and cementless metal-backed acetabular sockets in primary total hip arthroplasty.
    Hartofilakidis G; Georgiades G; Babis GC
    J Arthroplasty; 2009 Feb; 24(2):217-25. PubMed ID: 18534419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aseptic loosening.
    Wooley PH; Schwarz EM
    Gene Ther; 2004 Feb; 11(4):402-7. PubMed ID: 14724679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small ubiquitin-like modifier 1 [corrected] mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against Fas-induced apoptosis.
    Meinecke I; Pap G; Mendoza H; Drange S; Ender S; Strietholt S; Gay RE; Seyfert C; Ink B; Gay S; Pap T; Peters MA
    Arthritis Rheum; 2009 Jul; 60(7):2065-70. PubMed ID: 19565496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury.
    Yu WR; Liu T; Fehlings TK; Fehlings MG
    Eur J Neurosci; 2009 Jan; 29(1):114-31. PubMed ID: 19120440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants.
    Pajarinen J; Cenni E; Savarino L; Gomez-Barrena E; Tamaki Y; Takagi M; Salo J; Konttinen YT
    J Biomed Mater Res A; 2010 Jul; 94(1):84-92. PubMed ID: 20127718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance P stimulates production of interleukin 1beta and tumor necrosis factor alpha in fibroblasts from hip periprosthetic membrane.
    Qian Y; Zeng BF; Zhang XL; Jiang Y
    J Arthroplasty; 2008 Jun; 23(4):581-5. PubMed ID: 18514878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substance P augments PGE2 and IL-6 production in titanium particles-stimulated fibroblasts from hip periprosthetic membrane.
    Qian Y; Zeng BF; Zhang XL; Jiang Y
    J Biomed Mater Res A; 2007 Nov; 83(2):401-6. PubMed ID: 17450584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Release of TNF-alpha and activation of Caspase-3 during apoptosis of human mononuclear cell induced by metal ion].
    Xiong J; Dai M; Hao L; Qi Q; Zhan P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Mar; 23(3):299-302. PubMed ID: 19366138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Hydroxyapatite-coated stems in total hip arthroplasty after a minimum 10-years follow-up.
    Gallo J; Landor I; Cechová I; Jahoda D
    Acta Chir Orthop Traumatol Cech; 2008 Oct; 75(5):339-46. PubMed ID: 19026187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary total hip arthroplasty with a flattened press-fit acetabular component in osteoarthritis and inflammatory arthritis: a prospective study on 416 hips with 6-10 years follow-up.
    Zwartelé RE; Olsthoorn PG; Pöll RG; Brand R; Doets HC
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1379-86. PubMed ID: 18758793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current concepts in osteolysis.
    Ollivere B; Wimhurst JA; Clark IM; Donell ST
    J Bone Joint Surg Br; 2012 Jan; 94(1):10-5. PubMed ID: 22219240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonsurgical management of osteolysis: challenges and opportunities.
    Talmo CT; Shanbhag AS; Rubash HE
    Clin Orthop Relat Res; 2006 Dec; 453():254-64. PubMed ID: 17016218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of alendronate on pseudomembrane cytokine expression in patients with aseptic osteolysis.
    Holt G; Reilly J; Meek RM
    J Arthroplasty; 2010 Sep; 25(6):958-63. PubMed ID: 19963333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Periprosthetic wear particle migration and distribution modelling and the implication for osteolysis in cementless total hip replacement.
    Alidousti H; Taylor M; Bressloff NW
    J Mech Behav Biomed Mater; 2014 Apr; 32():225-244. PubMed ID: 24495400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.